Duration of anticoagulation after isolated pulmonary embolism

European Respiratory Journal

Volumn 47, Issue 5, 2016, Pages 1429-1435

  Palareti, Gualtiero ^a   Cosmi, Benilde ^b   Antonucci, Emilia ^c   Legnani, Cristina ^b   Erba, Nicoletta ^d   Ghirarduzzi, Angelo ^e   Poli, Daniela ^f   Testa, Sophie ^g   Tosetto, Alberto ^h   Pengo, Vittorio ⁱ   Prandoni, Paolo ⁱ  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c Fondazione Arianna Anticoagulazione   (Italy)

^d A MANZONI HOSPITAL   (Italy)

^e S MARIA NUOVA HOSPITAL   (Italy)

^f University Hospital   (Italy)

^g CREMONA HOSPITAL   (Italy)

^h Hospital of Vicenza   (Italy)

ⁱ UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

D DIMER; ANTICOAGULANT AGENT; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; FEMALE; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; RISK ASSESSMENT; SEX DIFFERENCE; TREATMENT DURATION; BLOOD CLOTTING; BODY MASS; FIBRINOLYTIC THERAPY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; PROSPECTIVE STUDY; RISK FACTOR; SEX FACTOR; VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM;

ADULT; AGED; ANTICOAGULANTS; BLOOD COAGULATION; BODY MASS INDEX; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; PROSPECTIVE STUDIES; PULMONARY EMBOLISM; RISK FACTORS; SEX FACTORS; THROMBOLYTIC THERAPY; VENOUS THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 84969869881     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/13993003.01126-2015     Document Type: Article

References (20)

1. Christiansen SC, Cannegieter SC, Koster T, et al. Thrombophilia, clinical factors, and recurrent venous thrombotic events. JAMA 2005; 293: 2352-2361.
2. White RH. The epidemiology of venous thromboembolism. Circulation 2003; 107: Suppl. 1, I4-I8.
3. Prandoni P, Noventa F, Ghirarduzzi A, et al. The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1, 626 patients. Haematologica 2007; 92: 199-205.
4. Eichinger S, Weltermann A, Minar E, et al. Symptomatic pulmonary embolism and the risk of recurrent venous thromboembolism. Arch Intern Med 2004; 164: 92-96.
5. Jiménez D, Díaz G, Marín E, et al. The risk of recurrent venous thromboembolism in patients with unprovoked symptomatic deep vein thrombosis and asymptomatic pulmonary embolism. Thromb Haemost 2006; 95: 562-566.
6. Baglin T, Douketis J, Tosetto A, et al. Does the clinical presentation and extent of venous thrombosis predict likelihood and type of recurrence? A patient-level meta-analysis. J Thromb Haemost 2010; 8: 2436-2442.
7. Kovacs MJ, Kahn SR, Wells PS, et al. Patients with a first symptomatic unprovoked deep vein thrombosis are at higher risk of recurrent venous thromboembolism than patients with a first unprovoked pulmonary embolism. J Thromb Haemost 2010; 8: 1926-1932.
8. Douketis JD, Gu CS, Schulman S, et al. The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism. Ann Intern Med 2007; 147: 766-774.
9. Palareti G, Cosmi B, Legnani C, et al. D-dimer to guide the duration of anticoagulation in patients with venous thromboembolism: A management study. Blood 2014; 124: 196-203.
10. Legnani C, Cini M, Cosmi B, et al. Age and gender specific cut-off values to improve the performance of D-dimer assays to predict the risk of venous thromboembolism recurrence. Intern Emerg Med 2013; 8: 229-236.
11. Rothman KJ, Greenland S. Modern Epidemiology. 2nd Edn. Philadelphia, Lippincott Williams & Wilkins, 1998.
12. Iorio A, Kearon C, Filippucci E, et al. Risk of recurrence after a first episode of symptomatic venous thromboembolism provoked by a transient risk factor: A systematic review. Arch Intern Med 2010; 170: 1710-1716.
13. Silverstein MD, Heit JA, Mohr DN, et al. Trends in the incidence of deep vein thrombosis and pulmonary embolism: A 25-year population-based study. Arch Intern Med 1998; 158: 585-593.
14. Oger E. Incidence of venous thromboembolism: A community-based study in Western France. Thromb Haemost 2000; 83: 657-660.
15. Heit JA, Silverstein MD, Mohr DN, et al. The epidemiology of venous thromboembolism in the community. Thromb Haemost 2001; 86: 452-463.
16. Talbot S. Epidemiological features of pulmonary embolism. Br J Clin Pract 1972; 26: 257-262.
17. Coon WW, Coller FA. Some epidemiologic considerations of thromboembolism. Surg Gynecol Obstet 1959; 109: 487-501.
18. DeMonaco NA, Dang Q, Kapoor WN, et al. Pulmonary embolism incidence is increasing with use of spiral computed tomography. Am J Med 2008; 121: 611-617.
19. Moysidis T, Kröger K, Moerchel C, et al. Pulmonary embolism in young males and females in Germany: data from the Federal Statistical Office. Blood Coagul Fibrinolysis 2010; 21: 511-515.
20. Lapostolle F, Le Toumelin P, Chassery C, et al. Gender as a risk factor for pulmonary embolism after air travel. Thromb Haemost 2009; 102: 1165-1168.